TFF1 activates p53 through down-regulation of miR-504 in gastric cancer

Mohammed Soutto, Zheng Chen, Mohamed A. Saleh, Ahmed Katsha, Shoumin Zhu, Alexander Zaika, Abbes Belkhiri, Wael El-Rifai

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The expression of TFF1 is frequently down-regulated in human gastric cancer whereas its knockout leads to the development of gastric adenomas and carcinomas in mouse models. The molecular mechanisms underlying the TFF1 tumor suppressor functions remain unclear. In this study, we demonstrate, using colony formation assay and Annexin V staining, that reconstitution of TFF1 expression in gastric cancer cell models suppresses cell growth and promotes cell death. Furthermore, using a tumor xenograft mouse model of gastric cancer, we demonstrated that reconstitution of TFF1 suppresses tumor growth in vivo. The results from PG13-luciferase reporter assay and Western blot analysis indicated that TFF1 promotes the expression and transcription activity of p53 protein. Further analysis using cycloheximide-based protein assay and quantitative real-time PCR data suggested that TFF1 does not interfere with p53 mRNA levels or protein stability. Alternatively, we found that the reconstitution of TFF1 down-regulates miR-504, a negative regulator of p53. Western blot analysis data demonstrated that miR-504 abrogates TFF1-induced p53 protein expression and activity. In conclusion, the in vitro and in vivo data demonstrate, for the first time, a novel mechanism by which the tumor suppressor functions of TFF1 involve activation of p53 through down-regulation of miR-504.

Original languageEnglish (US)
Pages (from-to)5663-5673
Number of pages11
JournalOncotarget
Volume5
Issue number14
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Stomach Neoplasms
Down-Regulation
Neoplasms
Western Blotting
Proteins
Protein Stability
Annexin A5
RNA Stability
Cycloheximide
Growth
Luciferases
Heterografts
Adenoma
Real-Time Polymerase Chain Reaction
Stomach
Cell Death
Staining and Labeling
Carcinoma

Keywords

  • Apoptosis
  • Gastric cancer
  • MiR-504
  • P53
  • TFF1

ASJC Scopus subject areas

  • Oncology

Cite this

TFF1 activates p53 through down-regulation of miR-504 in gastric cancer. / Soutto, Mohammed; Chen, Zheng; Saleh, Mohamed A.; Katsha, Ahmed; Zhu, Shoumin; Zaika, Alexander; Belkhiri, Abbes; El-Rifai, Wael.

In: Oncotarget, Vol. 5, No. 14, 01.01.2014, p. 5663-5673.

Research output: Contribution to journalArticle

Soutto, M, Chen, Z, Saleh, MA, Katsha, A, Zhu, S, Zaika, A, Belkhiri, A & El-Rifai, W 2014, 'TFF1 activates p53 through down-regulation of miR-504 in gastric cancer', Oncotarget, vol. 5, no. 14, pp. 5663-5673. https://doi.org/10.18632/oncotarget.2156
Soutto, Mohammed ; Chen, Zheng ; Saleh, Mohamed A. ; Katsha, Ahmed ; Zhu, Shoumin ; Zaika, Alexander ; Belkhiri, Abbes ; El-Rifai, Wael. / TFF1 activates p53 through down-regulation of miR-504 in gastric cancer. In: Oncotarget. 2014 ; Vol. 5, No. 14. pp. 5663-5673.
@article{6cf1a97798d7489db0a9e391d4ec03eb,
title = "TFF1 activates p53 through down-regulation of miR-504 in gastric cancer",
abstract = "The expression of TFF1 is frequently down-regulated in human gastric cancer whereas its knockout leads to the development of gastric adenomas and carcinomas in mouse models. The molecular mechanisms underlying the TFF1 tumor suppressor functions remain unclear. In this study, we demonstrate, using colony formation assay and Annexin V staining, that reconstitution of TFF1 expression in gastric cancer cell models suppresses cell growth and promotes cell death. Furthermore, using a tumor xenograft mouse model of gastric cancer, we demonstrated that reconstitution of TFF1 suppresses tumor growth in vivo. The results from PG13-luciferase reporter assay and Western blot analysis indicated that TFF1 promotes the expression and transcription activity of p53 protein. Further analysis using cycloheximide-based protein assay and quantitative real-time PCR data suggested that TFF1 does not interfere with p53 mRNA levels or protein stability. Alternatively, we found that the reconstitution of TFF1 down-regulates miR-504, a negative regulator of p53. Western blot analysis data demonstrated that miR-504 abrogates TFF1-induced p53 protein expression and activity. In conclusion, the in vitro and in vivo data demonstrate, for the first time, a novel mechanism by which the tumor suppressor functions of TFF1 involve activation of p53 through down-regulation of miR-504.",
keywords = "Apoptosis, Gastric cancer, MiR-504, P53, TFF1",
author = "Mohammed Soutto and Zheng Chen and Saleh, {Mohamed A.} and Ahmed Katsha and Shoumin Zhu and Alexander Zaika and Abbes Belkhiri and Wael El-Rifai",
year = "2014",
month = "1",
day = "1",
doi = "10.18632/oncotarget.2156",
language = "English (US)",
volume = "5",
pages = "5663--5673",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "14",

}

TY - JOUR

T1 - TFF1 activates p53 through down-regulation of miR-504 in gastric cancer

AU - Soutto, Mohammed

AU - Chen, Zheng

AU - Saleh, Mohamed A.

AU - Katsha, Ahmed

AU - Zhu, Shoumin

AU - Zaika, Alexander

AU - Belkhiri, Abbes

AU - El-Rifai, Wael

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The expression of TFF1 is frequently down-regulated in human gastric cancer whereas its knockout leads to the development of gastric adenomas and carcinomas in mouse models. The molecular mechanisms underlying the TFF1 tumor suppressor functions remain unclear. In this study, we demonstrate, using colony formation assay and Annexin V staining, that reconstitution of TFF1 expression in gastric cancer cell models suppresses cell growth and promotes cell death. Furthermore, using a tumor xenograft mouse model of gastric cancer, we demonstrated that reconstitution of TFF1 suppresses tumor growth in vivo. The results from PG13-luciferase reporter assay and Western blot analysis indicated that TFF1 promotes the expression and transcription activity of p53 protein. Further analysis using cycloheximide-based protein assay and quantitative real-time PCR data suggested that TFF1 does not interfere with p53 mRNA levels or protein stability. Alternatively, we found that the reconstitution of TFF1 down-regulates miR-504, a negative regulator of p53. Western blot analysis data demonstrated that miR-504 abrogates TFF1-induced p53 protein expression and activity. In conclusion, the in vitro and in vivo data demonstrate, for the first time, a novel mechanism by which the tumor suppressor functions of TFF1 involve activation of p53 through down-regulation of miR-504.

AB - The expression of TFF1 is frequently down-regulated in human gastric cancer whereas its knockout leads to the development of gastric adenomas and carcinomas in mouse models. The molecular mechanisms underlying the TFF1 tumor suppressor functions remain unclear. In this study, we demonstrate, using colony formation assay and Annexin V staining, that reconstitution of TFF1 expression in gastric cancer cell models suppresses cell growth and promotes cell death. Furthermore, using a tumor xenograft mouse model of gastric cancer, we demonstrated that reconstitution of TFF1 suppresses tumor growth in vivo. The results from PG13-luciferase reporter assay and Western blot analysis indicated that TFF1 promotes the expression and transcription activity of p53 protein. Further analysis using cycloheximide-based protein assay and quantitative real-time PCR data suggested that TFF1 does not interfere with p53 mRNA levels or protein stability. Alternatively, we found that the reconstitution of TFF1 down-regulates miR-504, a negative regulator of p53. Western blot analysis data demonstrated that miR-504 abrogates TFF1-induced p53 protein expression and activity. In conclusion, the in vitro and in vivo data demonstrate, for the first time, a novel mechanism by which the tumor suppressor functions of TFF1 involve activation of p53 through down-regulation of miR-504.

KW - Apoptosis

KW - Gastric cancer

KW - MiR-504

KW - P53

KW - TFF1

UR - http://www.scopus.com/inward/record.url?scp=84906225090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906225090&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.2156

DO - 10.18632/oncotarget.2156

M3 - Article

C2 - 25015107

AN - SCOPUS:84906225090

VL - 5

SP - 5663

EP - 5673

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 14

ER -